Case studies
Working with our customers to reduce time to market, deliver on quality, provide deep therapeutic expertise, and enhance R&D ROI.
Highlights
We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.
Proactive patient retention strategy in a GLP-1 RA trial
Explore how ICON successfully supported a sponsor’s cardiovascular outcome trial for a GLP-1 receptor agonist with 9,900+ patients with type 2 diabetes and maintained a retention rate of 97% over 7 years.
A small biotech success story
A small US-based biotech company was in a race to be the first to market with their lead targeted oncology product.
FSP partnership - sustained efficiency and ongoing innovation
The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.
By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.
All case studies
Select amongst our broad range of solutions and experience.
Machine translation for pharmacovigilance
ICON Language Services was tasked with translating medical reports and individual case review forms in five languages using machine translation post editing methodology.
COA Linguistic Validation rescue study
ICON Language Services rapidly remediated quality and timeline risks for a top global pharma company’s clinical trials delivering 240+ files with zero critical findings and restoring compliance, timelines, and data integrity.
On-demand Medical Writing solution
A mid-sized, global biopharmaceutical company specialising in rare diseases and neurodegenerative disorders,
including ALS and Parkinson’s, needed a scalable cost-effective solution to manage periodic surges in medical
writing demand. The company maintains a global workforce of over 5,000 employees and utilises an embedded
ICON FSP medical writing team of five to support its portfolio.
including ALS and Parkinson’s, needed a scalable cost-effective solution to manage periodic surges in medical
writing demand. The company maintains a global workforce of over 5,000 employees and utilises an embedded
ICON FSP medical writing team of five to support its portfolio.
Global, full-service delivery for complex psychedelic trials
How ICON delivered a multinational psychedelic programme across 12 countries and 150+ sites.
Expanding Biometrics and Data Management capabilities in India within mid-size pharma
This case study explores how a sponsor partnered with ICON to scale biometrics and data management in India, achieving rapid growth, cost efficiencies, and seamless global delivery.
Maximising data capture in obesity trials
A global Phase 2/3 obesity trial leveraged a scalable DXA imaging strategy to overcome equipment limitations and eliminate ‘silent attrition,’ ensuring complete visceral fat data capture across a diverse, multi‑site network.
ADME and ABA trial in solid tumor patients
This phase 1 oncology ADME and ABA study faced strict eligibility, screening, radiolabeled drug logistics, and 72-hour shelf-life constraints, requiring precise coordination, specialised expertise and patient recruitment.
Seamless collaboration on a complex co-sponsored oncology study in three APAC locations
A Europe-based biotech company that had recently gone public sought ICON’s support on a global oncology
study. The study investigated a novel treatment of advanced solid tumours in the head and neck.
study. The study investigated a novel treatment of advanced solid tumours in the head and neck.
Country in a box - Clinical trial delivery across emerging countries
ICON supported biotech expansion into emerging markets by delivering complex clinical trials in Brazil and KSA through tailored strategies and an innovative FSP model that ensured full operational continuity.
Streamlining global budget development & negotiation
A leading medical device company partnered with ICON to streamline budget development and negotiation for a retrospective data collection study involving 158 participants, 26 sites, and 5 countries across the United States and Europe.
Navigating consent, regulatory requirements, and data challenges in a multi‑country vascular graft study
A medical device company partnered with ICON to conduct a retrospective study using existing patient data from European sites, rather than enrolling new patients. Sites contributed up to five years of historical information across multiple vascular graft cohorts.
Ensuring protocol compliance in an Alzheimer’s study
A drug development sponsor sought help in recruiting patients for a study on the efficacy of a recombinant humanised Igg4P monoclonal antibody in prodomal to mild Alzheimer’s disease (AD).
Let's collaborate
Discover how ICON's expertise transforms clinical trials.